Medical Technologies Enterprise Consortium

The Medical Technology Enterprise Consortium (MTEC) is a 501(c)(3) biomedical technology consortium collaborating under an Other Transaction Agreement (OTA) with the U.S. Army Medical Research and Development Command (USAMRDC) that serves those who serve our nation. Over the last decades, our warfighters have suffered devastating trauma. So much injury, so many lives compromised. We need solutions and we need them now. In partnership with the Department of Defense and private support, MTEC is working to prevent injuries and accelerate the development of revolutionary medical solutions that will enhance wound healing, and return the wounded to fully functioning lives. Ultimately, all citizens will benefit from these technologies and health care solutions.

We focus on building teams to solve problems. Our research priorities are purposeful and outcome driven. The reach of the MTEC team ensures that research developments and new technologies will be applied across the entire medical infrastructure for the benefit of the military, veterans, and civilians. Our collaboration aims to advance biomedicine and create amazing new possibilities, such asincluding:

The Medical Technology Enterprise Consortium (MTEC) is a 501(c)(3) biomedical technology consortium collaborating under an Other Transaction Agreement (OTA) with the U.S. Army Medical Research and Development CommandU.S. Army Medical Research and Development Command (USAMRDC) that serves those who serve our nation. Over the last decades, our warfighters have suffered devastating trauma. So much injury, so many lives compromised. We need solutions and we need them now. In partnership with the Department of Defense and private support, MTEC is working to prevent injuries and accelerate the development of revolutionary medical solutions that will enhance wound healing, and return the wounded to fully functioning lives. Ultimately, all citizens will benefit from these technologies and health care solutions.

The Medical Technology Enterprise Consortium (MTEC) is a 501(c)(3) biomedical technology consortium collaborating under an Other Transaction Agreement (OTA) with the U.S. Army Medical Research and Development Command (USAMRDC) that serves those who serve our nation. Over the last decades, our warfighters have suffered devastating trauma. So much injury, so many lives compromised. We need solutions and we need them now. In partnership with the Department of Defense and private support, MTEC is working to prevent injuries and accelerate the development of revolutionary medical solutions that will enhance wound healing, and return the wounded to fully functioning lives. Ultimately, all citizens will benefit from these technologies and health care solutions.

We focus on building teams to solve problems. Our research priorities are purposeful and outcome driven. The reach of the MTEC team ensures that research developments and new technologies will be applied across the entire medical infrastructure for the benefit of the military, veterans, and civilians. Our collaboration aims to advance biomedicine and create amazing new possibilities, such as:

Providing sight to those who have lost their vision

Providing battlefield diagnostics and therapies to reduce the consequences of traumatic brain injury (TBI) and concussions

Developing evidence-based therapies for post-traumatic stress disorder to integrate warfighters back into families and society

Advancing cell therapies that heal previously irreparable nerve, vascular and organ damage

Developing new antibiotics to cure life‐threatening infections

Improving telehealth solutions that monitor warfighter health conditions during training and in battle

Reducing substance abuse during chronic pain relief

Commercializing cutting‐edge artificial limbs with greater comfort and functionality in the near term, and, in the longer term, providing limb transplants or regenerative medicine therapies to restore normal functions like walking, grasping and writing

Empowering medics through new advanced technologies to do more treatment at the point of injury